This tiny brain implant could treat depression at home
Motif Neurotech has received FDA approval to begin human trials for a tiny brain implant designed to treat treatment-resistant depression by stimulating brain regions involved in mood regulation. The device, implanted in the skull above the brain's protective membrane, delivers targeted electrical pulses to reactivate neural networks that are underactive in depression. The procedure takes about 20 minutes, does not require traditional brain surgery, and is controlled wirelessly via a specially designed baseball cap.
Opening excerpt (first ~120 words) tap to expand
Nearly 3 million Americans suffer from treatment-resistant depression, meaning antidepressants simply don’t work for them. Motif Neurotech wants to change that with a tiny brain implant, and the FDA has just greenlighted a human trial to test it. As reported by Wired, the Houston-based startup has developed a tiny device that sits in the skull, just above the brain’s protective membrane. It targets the part of the brain responsible for high-level thinking that tends to go quiet in people with major depressive disorder. The implant delivers precise electrical pulses to wake that network back up.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Digital Trends.